Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07674303 · ClinicalTrials.gov registry record · NA
Multi-Site Feasibility Testing a Meditation App for Youth in the Legal System
A NA study, sponsored by University of Illinois at Chicago.
- Not yet
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT07674303: Clinical Trial NA study, sponsored by University of Illinois at Chicago.
NCT07674303 is a NA study that has not yet begun recruiting, run by University of Illinois at Chicago. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07674303, a NA study, has not yet begun recruiting, sponsored by University of Illinois at Chicago.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
This multi-site feasibility clinical trial aims to assess the feasibility of implementing a 1-month app-based meditation program with youth in 4 heterogeneous juvenile legal systems across Oregon and New York. The primary question it is designed to answer is: Will youth adequately adhere to the 1-month meditation app across sites? Secondary feasibility outcomes pertain to recruitment, randomization, retention, and survey completion.
Primary Outcome
Percentage of participants who play at least one file on their study app after baseline.
Interventions
- BEHAVIORAL Bodhi AIM
- BEHAVIORAL HIB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-06 |
| Phase | NA |
What is known before NCT07674303 opens enrollment
NCT07674303 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Bodhi AIM is the first listed.
NCT07674303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07674303 about?
NCT07674303 is a clinical study titled "Multi-Site Feasibility Testing a Meditation App for Youth in the Legal System". This multi-site feasibility clinical trial aims to assess the feasibility of implementing a 1-month app-based meditation program with youth in 4 heterogeneous juvenile legal systems across Oregon and New York. The primary question it is designed to answer is: Will youth adequately adhere to the 1-mo...
What is the current status of trial NCT07674303?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-07. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07674303?
The interventions under investigation include: Bodhi AIM (BEHAVIORAL), HIB (BEHAVIORAL).
Who is sponsoring clinical trial NCT07674303?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07674303's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia